JMI Syringes & Medical Devices (DHA:JMISMDL) Debt-to-EBITDA

: 0.28 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

JMI Syringes & Medical Devices's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was BDT42 Mil. JMI Syringes & Medical Devices's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was BDT1 Mil. JMI Syringes & Medical Devices's annualized EBITDA for the quarter that ended in Dec. 2023 was BDT155 Mil. JMI Syringes & Medical Devices's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.28.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for JMI Syringes & Medical Devices's Debt-to-EBITDA or its related term are showing as below:

DHA:JMISMDL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.25 Med: 0.88 Max: 6.94
Current: 0.36

During the past 13 years, the highest Debt-to-EBITDA Ratio of JMI Syringes & Medical Devices was 6.94. The lowest was 0.25. And the median was 0.88.

DHA:JMISMDL's Debt-to-EBITDA is ranked better than
76.57% of 431 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs DHA:JMISMDL: 0.36

JMI Syringes & Medical Devices Debt-to-EBITDA Historical Data

The historical data trend for JMI Syringes & Medical Devices's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JMI Syringes & Medical Devices Annual Data

Trend

Dec14

Dec15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-EBITDA

0.32

0.54

0.25

0.74

0.88

JMI Syringes & Medical Devices Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-EBITDA																1.41	1.38	1.70	0.58	0.28

Competitive Comparison

For the Medical Instruments & Supplies subindustry, JMI Syringes & Medical Devices's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JMI Syringes & Medical Devices Debt-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, JMI Syringes & Medical Devices's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where JMI Syringes & Medical Devices's Debt-to-EBITDA falls into.

JMI Syringes & Medical Devices Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

JMI Syringes & Medical Devices's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(131.009	+	1.833)	/	151.662
	=	0.88

JMI Syringes & Medical Devices's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(42.336	+	1.441)	/	155.484
	=	0.28

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

JMI Syringes & Medical Devices (DHA:JMISMDL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

JMI Syringes & Medical Devices Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of JMI Syringes & Medical Devices's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

JMI Syringes & Medical Devices (DHA:JMISMDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » JMI Syringes & Medical Devices Ltd (DHA:JMISMDL) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217

Website

https://www.jmisyringe.com

JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.

JMI Syringes & Medical Devices (DHA:JMISMDL) Headlines

No Headlines